Table 1.

Study assessment tools and assessment time schedule.

Timepoint	Enrollment	Randomization	Postrandomization
	–t1	t0	t1	t2	t3	t4	t5	t6
		0 weeks	2 weeks	4 weeks	8 weeks	12 weeks	3 months	6 months
MINI6.0.0	■
Demographic information	■
HAMA	■	■	■	■	■	■	■	■
HAMD-17	■	■	■	■	■	■	■	■
GAD-7		■	■	■	■	■	■	■
PHQ-9		■	■	■	■	■	■	■
ISI		■				■	■	■
CGI			■	■	■	■	■	■
TESS			■	■	■	■	■	■
SASE						■	■	■
SDSS		■	■	■	■	■	■	■
WHO-QOL-Brief		■	■	■	■	■	■	■
TAS-20		■				■	■	■
CERQ		■				■	■	■
LSAS		■	■	■	■	■	■	■
PDSS		■	■	■	■	■	■	■

MINI6.0.0, Mini International Neuro-psychiatry Interview (Version 6.0.0); HAMA, Hamilton Anxiety Rating Scale; HAMD-17, the 17-item Hamilton Depression Scale; GAD-7, Generalized Anxiety Disorder-7; PHQ-9, Patient Health Questionnaire-9; ISI, Insomnia Severity Index; CGI, Clinical Global Impression.

TESS, Treatment Emergent Symptom Scale; SASE, Self-Assessment Scale of the Overall Efficacy and Satisfaction of Patients; SDSS, Social Disability Screening Schedule; WHO-QOL-Brief, World Health Organization Quality of Life Brief Form; TAS-20, Toronto Alexithymia Scale; CERQ, Cognitive Emotion Regulation Questionnaire; LSAS, Liebowitz social anxiety scale; PDSS, Panic Disorder Severity Scale.